DE3007412A1 - Antitumormittel - Google Patents

Antitumormittel

Info

Publication number
DE3007412A1
DE3007412A1 DE19803007412 DE3007412A DE3007412A1 DE 3007412 A1 DE3007412 A1 DE 3007412A1 DE 19803007412 DE19803007412 DE 19803007412 DE 3007412 A DE3007412 A DE 3007412A DE 3007412 A1 DE3007412 A1 DE 3007412A1
Authority
DE
Germany
Prior art keywords
yit
cells
tumor
mouse
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19803007412
Other languages
German (de)
English (en)
Inventor
Tokio Hachioji
Ikuo Kato
Seizaburo Kobayashi
Masahiko Mutai
Teruo Yokokura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Publication of DE3007412A1 publication Critical patent/DE3007412A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE19803007412 1979-02-27 1980-02-27 Antitumormittel Ceased DE3007412A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2133979A JPS55113718A (en) 1979-02-27 1979-02-27 Antitumor agent

Publications (1)

Publication Number Publication Date
DE3007412A1 true DE3007412A1 (de) 1980-11-06

Family

ID=12052351

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803007412 Ceased DE3007412A1 (de) 1979-02-27 1980-02-27 Antitumormittel

Country Status (12)

Country Link
US (1) US4347240A (OSRAM)
JP (1) JPS55113718A (OSRAM)
BR (1) BR8001129A (OSRAM)
CA (1) CA1124176A (OSRAM)
CH (1) CH653556A5 (OSRAM)
DE (1) DE3007412A1 (OSRAM)
FR (1) FR2450108B1 (OSRAM)
HK (1) HK23784A (OSRAM)
IT (1) IT1129802B (OSRAM)
MY (1) MY8500010A (OSRAM)
NL (1) NL189999C (OSRAM)
SG (1) SG38183G (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965414A (en) * 1985-11-04 1999-10-12 Microlife Technics, Inc. Process for producing yeast and mold inhibiting products with lactobacillus
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
WO1991005851A1 (en) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Bacterium strain lactobacillus casei subsp. casei 37 for production of a bacterial biological preparation
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
WO1997049820A1 (fr) 1996-06-26 1997-12-31 Kabushiki Kaisha Yakult Honsha Procedes de transfert de genes dans un chromosome
NZ337505A (en) * 1997-02-11 2001-07-27 Univ College Cork Nat Univ Ie Isolated antimicrobial agents from Lactobacillus salivarius
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
DE69832267T2 (de) * 1997-04-18 2006-08-10 Ganeden Biotech, Inc., La Jolla Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
WO2005000222A2 (en) * 2003-05-30 2005-01-06 Amylin Pharmaceuticals, Inc. Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
CA2534013C (en) * 2003-07-30 2010-11-02 Bhph Company Limited Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection
US20050112097A1 (en) * 2003-11-26 2005-05-26 Hinton Golden S. Method for the treatment of cancer
CA2597229A1 (en) * 2005-02-11 2006-08-17 Technologie Biolactis Inc. Use of lactobacillus kefiranofaciens as a probiotic and a synbiotic
JPWO2008053588A1 (ja) * 2006-10-27 2010-02-25 株式会社ヤクルト本社 サイトカイン産生調節遺伝子及びその利用
WO2008053728A1 (en) * 2006-11-02 2008-05-08 Aureo Co., Ltd. Agent for promoting healing of living body
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
EP2498789B1 (en) 2009-11-11 2016-06-22 Alimentary Health Limited Probiotic bifidobacterium strain
ES2610829T3 (es) 2009-11-11 2017-05-03 Alimentary Health Limited Cepa de Bifidobacterium
WO2018158309A1 (en) 2017-02-28 2018-09-07 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
EP3601525B1 (en) 2017-03-23 2024-03-06 Universiteit Antwerpen Probiotic lactobacillus casei strain and its uses
EP4117697A1 (en) 2020-03-13 2023-01-18 PrecisionBiotics Group Limited Bifidobacterium longum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel

Also Published As

Publication number Publication date
NL189999B (nl) 1993-05-03
CH653556A5 (de) 1986-01-15
MY8500010A (en) 1985-12-31
IT1129802B (it) 1986-06-11
SG38183G (en) 1984-07-20
IT8067302A0 (it) 1980-02-27
NL189999C (nl) 1993-10-01
CA1124176A (en) 1982-05-25
BR8001129A (pt) 1980-11-04
FR2450108B1 (fr) 1988-10-28
JPS55113718A (en) 1980-09-02
US4347240A (en) 1982-08-31
NL8001045A (nl) 1980-08-29
JPS6234727B2 (OSRAM) 1987-07-28
HK23784A (en) 1984-03-23
FR2450108A1 (fr) 1980-09-26

Similar Documents

Publication Publication Date Title
DE3007412A1 (de) Antitumormittel
US4710379A (en) Intestinal microflora-improving agent
US4746512A (en) Anticariogenic or antiperiodontitic agent
DE2813733A1 (de) Verfahren zur herstellung von nahrungsmitteln und getraenken mit einem gehalt an bifidobakterien
DE69824016T2 (de) Fermentierte sojamilch hergestellt mit bifidobacterium breve yit 4065
DE2415461A1 (de) Verfahren zum erzeugen von algenzellen
DE2656160C2 (de) Lebensfähige Bifidobakterien enthaltendes, fermentiertes Milchprodukt und Verfahren zu seiner Herstellung
DE69723576T2 (de) Die eierschalen von geflügel stärkende zusammensetzung
DE69122186T2 (de) Laktobazillus acidophilus-f-133, herstellung von davon ausgehenden milchsäurebakterien und verfahren zu deren herstellung
DE1617397C3 (de) Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus
DE1492779B2 (de) Verfahren zum Herstellen von Sauermilchprodukten
GB2072502A (en) Antitumour agent comprising lactobacillus casei
CH639133A5 (de) Verfahren zur herstellung einer antitumor wirksamen substanz mit immunostimulierender wirkung.
DE2040440C3 (de) Enzym, mit der Fälligkeit zur Lyse der Zellen von Zahnkaries erzeugenden Mikroorganismen, Verfahren zur Herstellung desselben und dasselbe enthaltende Präparat zur Verhütung und Behandlung von Zahnkaries
DE2028403B2 (de) Pepstatin
DD291926A5 (de) Verfahren zur herstellung eines mittels gegen tonsillitis
DE2921829C2 (OSRAM)
DE2164018B2 (de) Verfahren zur biotechnischen herstellung von uricase
DE2363285A1 (de) Verfahren zur herstellung von lapfelsaeure durch mikrobiologische fermentation und mittel zur durchfuehrung des verfahrens
DE2011935B2 (de) Enzym mit der Fähigkeit zur Lyse der Zellen von Zahnkaries erzeugenden Mikroorganismen, Verfahren zur Herstellung dieses Enzyms sowie ein Präparat zur Verhütung und Behandlung von Zahnkaries
DE3030107C2 (OSRAM)
DE2737943A1 (de) Neue antibiotika, substanzen sf-1130- x tief 1 und -x tief 2 , verfahren zu ihrer herstellung und ihre verwendung
DE2833799A1 (de) Substanz 34129 rp, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
AT205663B (de) Verfahren zur Herstellung eines therapeutisch wirksamen Darmbaktierienpräparates
AT261115B (de) Verfahren zur Herstellung von Tetracyclin

Legal Events

Date Code Title Description
OD Request for examination
8131 Rejection